BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 24823914)

  • 21. Staging DLBCL: bone marrow biopsy or PET-CT?
    Avigdor A
    Blood; 2013 Jul; 122(1):4-5. PubMed ID: 23828884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Significance of Bone Marrow Involvement as Confirmed by Bone Marrow Aspiration vs. Bone Marrow Biopsy in Diffuse Large B-cell Lymphoma.
    Hantaweepant C; Chinthammitr Y; Khuhapinant A; Sukpanichnant S
    J Med Assoc Thai; 2016 Mar; 99(3):262-9. PubMed ID: 27276736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Value of PET/CT in Detecting Bone Marrow Involvement in Patients With Follicular Lymphoma.
    Perry C; Lerman H; Joffe E; Sarid N; Amit O; Avivi I; Kesler M; Ben-Ezra J; Even-Sapir E; Herishanu Y
    Medicine (Baltimore); 2016 Mar; 95(9):e2910. PubMed ID: 26945387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High total metabolic tumor volume in PET/CT predicts worse prognosis in diffuse large B cell lymphoma patients with bone marrow involvement in rituximab era.
    Song MK; Yang DH; Lee GW; Lim SN; Shin S; Pak KJ; Kwon SY; Shim HK; Choi BH; Kim IS; Shin DH; Kim SG; Oh SY
    Leuk Res; 2016 Mar; 42():1-6. PubMed ID: 26851438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone marrow biopsy can be omitted in the diagnostic workup of CNS lymphoma of DLBCL origin: a population-based retrospective study in the PET-CT era.
    Jelicic J; Hansen DL; Carlsen SS; Thorsgaard M; Hersby DS; Kannik K; Munksgaard ASE; Larsen TS; Juul-Jensen K
    Ann Hematol; 2023 Jul; 102(7):1897-1905. PubMed ID: 37246974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic Efficacy of
    Guo B; Qin R; Gu ZY; Li YF; Gao L; Huang WR
    Biomed Environ Sci; 2023 Jun; 36(6):510-516. PubMed ID: 37424244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accuracy of 18-F FDG PET/CT to detect bone marrow clearance in patients with peripheral T-cell lymphoma - tissue remains the issue.
    Pham AQ; Broski SM; Habermann TM; Jevremovic D; Wiseman GA; Feldman AL; Maurer MJ; Ristow KM; Witzig TE
    Leuk Lymphoma; 2017 Oct; 58(10):2342-2348. PubMed ID: 28290723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic Accuracy and Prognostic Relevance of Immunoglobulin Heavy Chain Rearrangement and 18F-FDG-PET/CT Compared With Unilateral Bone Marrow Trephination for Detecting Bone Marrow Involvement in Patients With Diffuse Large B-Cell Lymphoma.
    Kim M; Ahn SY; Ahn JS; Song GY; Jung SH; Lee JJ; Kim HJ; Lee JH; Shin MG; Song SY; Yang DH
    J Korean Med Sci; 2022 Jan; 37(1):e2. PubMed ID: 34981678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of bone marrow involvement in extranodal NK/T cell lymphoma by FDG-PET/CT.
    Zhou Z; Chen C; Li X; Li Z; Zhang X; Chang Y; Lu L; Cui Y; Ma Y; Zhang M
    Ann Hematol; 2015 Jun; 94(6):963-7. PubMed ID: 25547320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poor prognosis in patients with diffuse large B cell lymphomas with bone marrow involvement possessing chromosomal abnormalities, despite aggressive treatment.
    Min GJ; Jeon YW; Park SS; Shin SH; Yahng SA; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Kim DW; Lee JW; Cho SG
    Ann Hematol; 2020 Mar; 99(3):557-570. PubMed ID: 31989249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can flow cytometry of bone marrow aspirate predict outcome of patients with diffuse large B cell lymphoma? A retrospective single centre study.
    Wolach O; Fraser A; Luchiansky M; Shapiro C; Radnay J; Shpilberg O; Lishner M; Lahav M
    Hematol Oncol; 2015 Mar; 33(1):42-7. PubMed ID: 24470400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of diffuse large B-cell lymphoma patients with 64-slice multidetector computed tomography versus
    Gómez León N; Vega G; Rodríguez-Vigil Junco B; Suevos Ballesteros C
    Med Clin (Barc); 2018 Oct; 151(7):255-264. PubMed ID: 29705152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current status of the role of PET imaging in diffuse large B-cell lymphoma.
    Moskowitz CH; Schöder H
    Semin Hematol; 2015 Apr; 52(2):138-42. PubMed ID: 25805593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PET Scans for Staging and Restaging in Diffuse Large B-Cell and Follicular Lymphomas.
    Barrington SF; Mikhaeel NG
    Curr Hematol Malig Rep; 2016 Jun; 11(3):185-95. PubMed ID: 27095319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implications of infiltrating immune cells within bone marrow of patients with diffuse large B-cell lymphoma.
    Jeong J; Oh EJ; Yang WI; Kim SJ; Yoon SO
    Hum Pathol; 2017 Jun; 64():222-231. PubMed ID: 28438619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of bone marrow biopsy and FDG-PET/CT in identifying bone marrow infiltration in the initial diagnosis of high grade non-Hodgkin B-cell lymphoma and Hodgkin lymphoma. Accuracy in a multicenter series of 372 patients.
    Chen-Liang TH; Martin-Santos T; Jerez A; Senent L; Orero MT; Remigia MJ; Muiña B; Romera M; Fernandez-Muñoz H; Raya JM; Fernandez-Gonzalez M; Lancharro A; Villegas C; Carlos Herrera J; Frutos L; Luis Navarro J; Uña J; Igua C; Sanchez-Vaño R; Cozar Mdel P; Contreras J; Sanchez-Blanco JJ; Perez-Ceballos E; Ortuño FJ
    Am J Hematol; 2015 Aug; 90(8):686-90. PubMed ID: 25925613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of molecular staging by PCR-amplification of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma (DLBCL).
    Mitterbauer-Hohendanner G; Mannhalter C; Winkler K; Mitterbauer M; Skrabs C; Chott A; Simonitsch-Klupp I; Gleiss A; Lechner K; Jaeger U
    Leukemia; 2004 Jun; 18(6):1102-7. PubMed ID: 15085149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Diagnostic Accuracy of Bone Marrow Biopsy Versus PET/CT Scan in Identifying Bone Marrow Involvement in Diffuse Large B Cell Lymphoma Patients at a Cancer Hospital.
    Asif H; Zubair R; Siddiqui IA; Tariq Mahmood M; Jamil A; Tahir A
    Cureus; 2023 Feb; 15(2):e34901. PubMed ID: 36938170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of semiquantitative analysis in identifying diffuse bone marrow involvement in follicular lymphoma.
    El-Najjar I; Montoto S; McDowell A; Matthews J; Gribben J; Szyszko TA
    Nucl Med Commun; 2014 Mar; 35(3):311-5. PubMed ID: 24323311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome prediction by extranodal involvement, IPI, R-IPI, and NCCN-IPI in the PET/CT and rituximab era: A Danish-Canadian study of 443 patients with diffuse-large B-cell lymphoma.
    El-Galaly TC; Villa D; Alzahrani M; Hansen JW; Sehn LH; Wilson D; de Nully Brown P; Loft A; Iyer V; Johnsen HE; Savage KJ; Connors JM; Hutchings M
    Am J Hematol; 2015 Nov; 90(11):1041-6. PubMed ID: 26260224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.